Sense Biodetection raised €13M in a Series B round in Nov 2021. The company is based in Abingdon, UK. Investors in the round: Koch Disruptive Technologies. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
